|
(P1072) |
Die Überexpression von IRS-2 in glatten Gefäßmuskelzellen schützt vor Neointimabildung in den Arterien der Maus |
| |
|
A. Markl, N. Blank, K. Krysztofiak, E. M. Berghausen, K. Seidl, M. Schubert, M. Vantler, S. Rosenkranz (Ingolstadt, Köln, Rüdesheim am Rhein) |
|
(P1073) |
Differential effects of pravastatin and atorvastatin on endothelial cell proliferation and migration |
| |
|
F. Lorenz, A. Strohbach, S. B. Felix, M. Dörr, R. Busch, M. Bahls (Greifswald) |
|
(P1074) |
Approaches towards a perfusable starter matrix based on small intestinal submucosa for tissue engineered vascular constructs |
| |
|
A. Bendinger, B. Andrée, T. Horvath, A. Haverich, A. Hilfiker (Hannover) |
|
(P1075) |
miR-92a inhibition is cardioprotective in a pig model of hibernating myocardium |
| |
|
V. Kaczmarekt, R. Hinkel, A. Fischer, A. Howe, E. van Rooij, A. M. Zeiher, S. Dimmeler, C. Kupatt (München, Frankfurt am Main; Utrecht, NL) |
|
(P1076) |
The novel mineralocorticoid receptor antagonist Finerenone attenuates neointima formation after vascular injury |
| |
|
R.-J. Musmann, J. Dutzmann, J. M. Daniel, P. Kolkhof, K. Sonnenschein, T. Thum, J. Bauersachs, D. G. Sedding (Hannover, Wuppertal) |
|
(P1077) |
Light-inducible antimiR-92a as a therapeutic agent to promote healing in diabetic mice |
| |
|
T. Lucas, F. Schäfer, A. Heckel, S. Dimmeler (Frankfurt am Main, Frankfurt) |